Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A Mungall

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 23, 2023
In Vitro Antiviral Screening for Henipaviruses at BSL4Bruce A Mungall
Comparative Immunology, Microbiology and Infectious Diseases|July 17, 2007
Recent progress in henipavirus researchKim Halpin, Bruce A Mungall
Virus Research|May 28, 2004
Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasonsBruce A Mungall, Xiyan Xu, Alexander Klimov
Human Vaccines & Immunotherapeutics|January 7, 2021
A systematic review of the burden of pertussis in South KoreaBruce A Mungall, Hyungwoo Kim, Kyu-Bin Oh
Journal of Virological Methods|March 4, 2008
Development and validation of a chemiluminescent immunodetection assay amenable to high throughput screening of antiviral drugs for Nipah and Hendra virusMohamad Aljofan, Matteo Porotto, Anne Moscona, et al.
Expert Review of Vaccines|December 9, 2021
A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in childrenBruce A Mungall, Bernard Hoet, Javier Nieto Guevara, et al.
Virus Research|January 2, 2008
Henipavirus susceptibility to environmental variablesRhys Fogarty, Kim Halpin, Alex D Hyatt, et al.
Applied Health Economics and Health Policy|April 11, 2018
A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New ZealandLijoy Varghese, Louise Talbot, Andrea Govender, et al.
Antiviral Research|August 9, 2008
Inhibition of Henipavirus infection by RNA interferenceBruce A Mungall, Nick C T Schopman, Luke S Lambeth, et al.
Virus Research|May 12, 2009
Characteristics of Nipah virus and Hendra virus replication in different cell lines and their suitability for antiviral screeningMohamad Aljofan, Simon Saubern, Adam G Meyer, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|August 23, 2023
In Vitro Antiviral Screening for Henipaviruses at BSL4Bruce A Mungall
Comparative Immunology, Microbiology and Infectious Diseases|July 17, 2007
Recent progress in henipavirus researchKim Halpin, Bruce A Mungall
Virus Research|May 28, 2004
Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasonsBruce A Mungall, Xiyan Xu, Alexander Klimov
Human Vaccines & Immunotherapeutics|January 7, 2021
A systematic review of the burden of pertussis in South KoreaBruce A Mungall, Hyungwoo Kim, Kyu-Bin Oh
Journal of Virological Methods|March 4, 2008
Development and validation of a chemiluminescent immunodetection assay amenable to high throughput screening of antiviral drugs for Nipah and Hendra virusMohamad Aljofan, Matteo Porotto, Anne Moscona, et al.
Expert Review of Vaccines|December 9, 2021
A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in childrenBruce A Mungall, Bernard Hoet, Javier Nieto Guevara, et al.
Virus Research|January 2, 2008
Henipavirus susceptibility to environmental variablesRhys Fogarty, Kim Halpin, Alex D Hyatt, et al.
Applied Health Economics and Health Policy|April 11, 2018
A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New ZealandLijoy Varghese, Louise Talbot, Andrea Govender, et al.
Antiviral Research|August 9, 2008
Inhibition of Henipavirus infection by RNA interferenceBruce A Mungall, Nick C T Schopman, Luke S Lambeth, et al.
Virus Research|May 12, 2009
Characteristics of Nipah virus and Hendra virus replication in different cell lines and their suitability for antiviral screeningMohamad Aljofan, Simon Saubern, Adam G Meyer, et al.
Pageof 3